Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 0.12
- Piotroski Score 2.00
- Grade Buy
- Symbol (ABOS)
- Company Acumen Pharmaceuticals, Inc.
- Price $2.31
- Changes Percentage (-2.74%)
- Change -$0.07
- Day Low $2.26
- Day High $2.40
- Year High $5.09
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/24/2025
- Fiscal Year End N/A
- Average Stock Price Target $7.00
- High Stock Price Target $7.00
- Low Stock Price Target $7.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.05
- Trailing P/E Ratio -2.5
- Forward P/E Ratio -2.5
- P/E Growth -2.5
- Net Income $-52,371,000
Income Statement
Quarterly
Annual
Latest News of ABOS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Acumen Pharmaceuticals Inc (ABOS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
The company aims to maintain study integrity by not conducting interim reviews for ALTITUDE AD. They plan to release data at the study end and cannot disclose ARIA results until unblinded. The enrollm...
By Yahoo! Finance | 1 week ago -
Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds?
Islamic equity investing in debt-free Halal stocks has gained popularity among Muslim investors aligning with Shariah principles. Acumen Pharmaceuticals (NASDAQ: ABOS) is a promising buy with strong r...
By Yahoo! Finance | 5 months ago
